Targeting STAT3 and STAT5 in Cancer

Elvin D de Araujo; György M Keserű; Patrick T Gunning; Richard Moriggl

doi:10.3390/cancers12082002

Targeting STAT3 and STAT5 in Cancer

Cancers (Basel). 2020 Jul 22;12(8):2002. doi: 10.3390/cancers12082002.

Authors

Elvin D de Araujo^{1

2}, György M Keserű³, Patrick T Gunning^{1

2}, Richard Moriggl⁴

Affiliations

¹ Centre for Medicinal Chemistry, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.
² Department of Chemical and Physical Sciences, University of Toronto at Mississauga, Mississauga, ON L5L 1C6, Canada.
³ Medicinal Chemistry, Research Center for Natural Sciences, 1117 Budapest, Hungary.
⁴ Institute of Animal Breeding and Genetics, University of Veterinary Medicine, A-1210 Vienna, Austria.

Abstract

Insights into the mutational landscape of the human cancer genome coding regions defined about 140 distinct cancer driver genes in 2013, which approximately doubled to 300 in 2018 following advances in systems cancer biology studies [...].

Publication types

Editorial

Grants and funding

I 4157/FWF_/Austrian Science Fund FWF/Austria